{"entity":{"id":"beijing-scitech-mq-pharmaceuticals","kind":"company","name":"Beijing Scitech-Mq Pharmaceuticals","aka":["Beijing Scitech-Mq Pharmaceuticals Limited"],"tldr":"Beijing Scitech-Mq Pharmaceuticals is a Chinese developer in Beijing that sponsors 3 registered cancer trials of ST-1898.","summary":"Beijing Scitech-Mq Pharmaceuticals appears on ClinicalTrials.gov as the industry sponsor of 3 interventional cancer trials (phase 1/2, 2), testing ST-1898 in unresectable or metastatic melanoma, advanced renal cell carcinoma, differentiated thyroid carcinoma. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov: trials sponsored by Beijing Scitech-Mq Pharmaceuticals","url":"https://clinicaltrials.gov/search?spons=Beijing%20Scitech-Mq%20Pharmaceuticals"}],"tags":["ctgov-sponsor","china","registry-only"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06359860","nct06127238","nct06359847"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"Beijing, China","country":"CN","companyType":"biotech","investors":[],"funding":[]},"route":"/companies/beijing-scitech-mq-pharmaceuticals/","neighbours":{"trial":[{"id":"nct06359860","kind":"trial","name":"A Study of ST-1898 for Unresectable or Metastatic Melanoma","route":"/trials/nct06359860/"},{"id":"nct06127238","kind":"trial","name":"Study of ST-1898 in Advanced Renal Cell Carcinoma","route":"/trials/nct06127238/"},{"id":"nct06359847","kind":"trial","name":"Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer","route":"/trials/nct06359847/"}]}}